Peloton Therapeutics, Inc. Stock
Equities
PLTX
US70614L1044
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 17-10-31 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 10-12-31 |
David Chang
BRD | Director/Board Member | 64 | 18-01-31 |
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.14% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |